Peter Houston

Overcoming the challenges of digital brand management will involve choices in spending and channels.

For the life sciences industry in 2017, engaging across social media means less talking-and more listening.

Charles Benaiah, CEO of New York's watzan, tells Pharm Exec that the key to effective social media marketing is personalization.

How can Pharma balance the need to access to patient data and still respect patient privacy? One approach is to access patients through third-party online communities, writes Peter Houston.

In the brave new world of personalized medicine, there are concerns that the one-drug-fits-all mass-marketing approach of the past won’t work, writes Peter Houston.

It’s safe to say content marketing is here to stay, writes Peter Houston. So what is pharma doing with it?

Increasingly, media and marketing companies are looking to online video to rescue shrinking advertising rates and capture coveted social traffic. Peter Houston reports.

Last month Microsoft bought LinkedIn. What does this mean for pharm execs using the platform? Peter Houston reports.

Is Snapchat just for the kids, or should pharma marketers be taking it seriously as a media platform? Peter Houston takes a look.

Facebook is the number one social-media network for businesses. Peter Houston asks, How can pharma stay relevant in the feed?